Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 187989, 6 pages
http://dx.doi.org/10.1155/2014/187989
Research Article

Suppressive Effects of D-Glucosamine on the 5-HT Sensitive Nociceptive Units in the Rat Tooth Pulpal Nerve

1Department of Cariology, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto 1-7-1, Nagasaki 852-8588, Japan
2Department of Integrative Sensory Physiology, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto 1-7-1, Nagasaki 852-8588, Japan
3Department of Regenerative Oral Surgery, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto 1-7-1, Nagasaki 852-8588, Japan

Received 7 February 2014; Accepted 13 March 2014; Published 13 April 2014

Academic Editor: Hideo Kusaoke

Copyright © 2014 Kei Kaida et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Muzzarelli, “Depolymerization of chitins and chitosans with hemicellulase, lysozyme, papain and lipase,” in Chitin Handbook, R. A. A. Muzzarelli and M. G. Peter, Eds., pp. 153–163, Atec, Grottammare, Italy, 1997. View at Google Scholar
  2. J. Hua, K. Sakamoto, and I. Nagaoka, “Inhibitory actions of glucosamine, a therapeutic agent for osteoarthritis, on the functions of neutrophils,” Journal of Leukocyte Biology, vol. 71, no. 4, pp. 632–640, 2002. View at Google Scholar · View at Scopus
  3. J. Hua, S. Suguro, S. Hirano, K. Sakamoto, and I. Nagaoka, “Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats,” Inflammation Research, vol. 54, no. 3, pp. 127–132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Hua, S. Suguro, K. Iwabuchi, Y. Tsutsumi-Ishii, K. Sakamoto, and I. Nagaoka, “Glucosamine, a naturally occurring amino monosaccharide, suppresses the ADP-mediated platelet activation in humans,” Inflammation Research, vol. 53, no. 12, pp. 680–688, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Hua, K. Sakamoto, T. Kikukawa, C. Abe, H. Kurosawa, and I. Nagaoka, “Evaluation of the suppressive actions of glucosamine on the interleukin-1β-mediated activation of synoviocytes,” Inflammation Research, vol. 56, no. 10, pp. 432–438, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Shigemasa and S. Minami, “Applications of chitin and chitosan for biomaterials,” Biotechnology & Genetic Engineering Reviews, vol. 13, pp. 413–420, 1996. View at Google Scholar · View at Scopus
  7. R. A. A. Muzzarelli, M. Mattioli-Belmonte, A. Pugnaloni, and G. Biagini, “Biochemistry, histology and clinical uses of chitins and chitosans in wound healing,” in Chitin and Chitinases, P. Jolles and R. A. A. Muzzarelli, Eds., pp. 285–293, Birkhäuser, Basel, Switzerland, 1999. View at Google Scholar
  8. A. Drovanti, A. A. Bignamini, and A. L. Rovati, “Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation,” Clinical Therapeutics, vol. 3, no. 4, pp. 260–272, 1980. View at Google Scholar · View at Scopus
  9. E. D'Ambrosio, B. Casa, R. Bompani, G. Scali, and M. Scali, “Glucosamine sulphate: a controlled clinical investigation in arthrosis,” Pharmatherapeutica, vol. 2, no. 8, pp. 504–508, 1981. View at Google Scholar · View at Scopus
  10. J. M. Pujalte, E. P. Llavore, and F. R. Ylescupidez, “Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis,” Current Medical Research and Opinion, vol. 7, no. 2, pp. 110–114, 1980. View at Google Scholar · View at Scopus
  11. A. L. Vaz, “Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients,” Current Medical Research and Opinion, vol. 8, no. 3, pp. 145–149, 1982. View at Google Scholar · View at Scopus
  12. Y. Vajaradul, “Double-blind clinical evaluation of intra-articular glucosamine in outpatients with gonarthrosis,” Clinical Therapeutics, vol. 3, no. 5, pp. 336–343, 1981. View at Google Scholar · View at Scopus
  13. G. Crolle and E. D'Este, “Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation,” Current Medical Research and Opinion, vol. 7, no. 2, pp. 104–109, 1980. View at Google Scholar · View at Scopus
  14. L. S. Lohmander and E. M. Roos, “Clinical update: treating osteoarthritis,” The Lancet, vol. 370, no. 9605, pp. 2082–2084, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. S. Borer, H. Pouleur, E. Abadie et al., “Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval,” European Heart Journal, vol. 28, no. 15, pp. 1904–1909, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Zeidler, “Epidemiology of NSAID induced gastropathy,” Journal of Rheumatology, vol. 18, no. 28, pp. 2–5, 1991. View at Google Scholar · View at Scopus
  17. N. M. Newman and R. S. M. Ling, “Acetabular bone destruction related to non-steroidal anti-inflammatory drugs,” The Lancet, vol. 2, no. 8445, pp. 11–13, 1985. View at Google Scholar · View at Scopus
  18. K. Pavelká, J. Gatterová, M. Olejarová, S. Machacek, G. Giacovelli, and L. C. Rovati, “Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study,” Archives of Internal Medicine, vol. 162, no. 18, pp. 2113–2123, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. T. E. McAlindon, M. P. LaValley, J. P. Gulin, and D. T. Felson, “Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis,” Journal of the American Medical Association, vol. 283, no. 11, pp. 1469–1475, 2000. View at Google Scholar · View at Scopus
  20. J. Y. Reginster, R. Deroisy, L. C. Rovati et al., “Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial,” The Lancet, vol. 357, no. 9252, pp. 251–256, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Matsunaga, K. Yanagiguchi, S. Yamada, N. Ohara, T. Ikeda, and Y. Hayashi, “Chitosan monomer promotes tissue regeneration on dental pulp wounds,” Journal of Biomedical Materials Research A, vol. 76, no. 4, pp. 711–720, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Toda, N. Ishii, and Y. Nakamura, “An in vitro jaw-nerve preparation for oral sensory study in the rat,” Journal of Neuroscience Methods, vol. 61, no. 1-2, pp. 85–90, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. I. B. Bender, “Pulpal pain diagnosis—a review,” Journal of Endodontics, vol. 26, no. 3, pp. 175–179, 2000. View at Google Scholar · View at Scopus
  24. W. H. Xiao and G. J. Bennett, “Chemotherapy-evoked neuropathic pain: abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-l-carnitine,” Pain, vol. 135, no. 3, pp. 262–270, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Pavelká, J. Gatterová, M. Olejarová, S. Machacek, G. Giacovelli, and L. C. Rovati, “Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study,” Archives of Internal Medicine, vol. 162, no. 18, pp. 2113–2123, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. T. E. McAlindon, M. P. LaValley, J. P. Gulin, and D. T. Felson, “Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis,” The Journal of the American Medical Association, vol. 283, no. 11, pp. 1469–1475, 2000. View at Google Scholar · View at Scopus
  27. K. Kaida, H. Yamashita, K. Toda, and Y. Hayashi, “Effects of glucosamine on tooth pulpal nociceptive responses in the rat,” Journal of Dental Sciences, vol. 8, no. 1, pp. 68–73, 2013. View at Google Scholar
  28. L. S. Premkumar and G. P. Ahern, “Induction of vanilloid receptor channel activity by protein kinase C,” Nature, vol. 408, no. 6815, pp. 985–990, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Vellani, S. Mapplebeck, A. Moriondo, J. B. Davis, and P. A. McNaughton, “Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide,” Journal of Physiology, vol. 534, no. 3, pp. 813–825, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Sugiura, K. Bielefeldt, and G. F. Gebhart, “TRPV1 function in mouse colon sensory neurons is enhanced by metabotropic 5-hydroxytryptamine receptor activation,” The Journal of Neuroscience, vol. 24, no. 43, pp. 9521–9530, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Marchais and A. Marty, “Action of glucosamine on acetylcholine-sensitive channels,” Journal of Membrane Biology, vol. 56, no. 1, pp. 43–48, 1980. View at Google Scholar · View at Scopus
  32. M. Rogers, L. Tang, D. J. Madge, and E. B. Stevens, “The role of sodium channels in neuropathic pain,” Seminars in Cell & Developmental Biology, vol. 17, no. 5, pp. 571–581, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. T. R. Cummins, P. L. Sheets, and S. G. Waxman, “The roles of sodium channels in nociception: implications for mechanisms of pain,” Pain, vol. 131, no. 3, pp. 243–257, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Vajaradul, “Double-blind clinical evaluation of intra-articular glucosamine in outpatients with gonarthrosis,” Clinical Therapeutics, vol. 3, no. 5, pp. 336–343, 1981. View at Google Scholar · View at Scopus
  35. A. L. Vaz, “Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients,” Current Medical Research and Opinion, vol. 8, no. 3, pp. 145–149, 1982. View at Google Scholar · View at Scopus
  36. H. A. Wieland, M. Michaelis, B. J. Kirshbaum, and K. A. Rudolphi, “Osteoarthritis: an untreatable disease?” Nature Reviews Drug Discovery, vol. 4, no. 4, pp. 331–334, 2005. View at Google Scholar
  37. S. Rashad, P. Revell, A. Hemingway, F. Low, K. Rainsford, and F. Walker, “Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis,” The Lancet, vol. 2, no. 8662, pp. 519–522, 1989. View at Google Scholar · View at Scopus
  38. M. E. Adams, A. J. Lussier, and J. G. Peyron, “A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee,” Drug Safety, vol. 23, no. 2, pp. 115–130, 2000. View at Google Scholar · View at Scopus
  39. A. D. Sawitzke, H. Shi, M. F. Finco et al., “The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial,” Arthritis and Rheumatism, vol. 58, no. 10, pp. 3183–3191, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Scholtissen, O. Bruyère, A. Neuprez et al., “Glucosamine sulphate in the treatment of knee osteoarthritis: cost-effectiveness comparison with paracetamol,” International Journal of Clinical Practice, vol. 64, no. 6, pp. 756–762, 2010. View at Publisher · View at Google Scholar · View at Scopus